0000950170-24-018785.txt : 20240222 0000950170-24-018785.hdr.sgml : 20240222 20240222161822 ACCESSION NUMBER: 0000950170-24-018785 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brainard Diana CENTRAL INDEX KEY: 0001818070 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39409 FILM NUMBER: 24665064 MAIL ADDRESS: STREET 1: C/O ALLOVIR, INC. STREET 2: 139 MAIN STREET, SUITE 500 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allovir, Inc. CENTRAL INDEX KEY: 0001754068 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831971007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (617) 433-2605 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: ViraCyte, Inc. DATE OF NAME CHANGE: 20180924 4 1 ownership.xml 4 X0508 4 2024-02-20 0001754068 Allovir, Inc. ALVR 0001818070 Brainard Diana C/O ALLOVIR, INC. 1100 WINTER STREET WALTHAM MA 02451 true true false false Chief Executive Officer false Common Stock 2024-02-20 4 S false 3097 0.6952 D 819224 D Common Stock 2024-02-21 4 S false 5155 0.7081 D 814069 D Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.6832 to $0.7150. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.7002 to $0.7098. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Brett Hagen, as Attorney-in-Fact 2024-02-22